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Oxygen and nutrient delivery in developing embryos depends on the formation of vascular networks, and 
many pathologies, including solid tumor growth, also involve 
the development and remodeling of blood vessels.1 Growth 
factors released from nutrient-deprived tissues initiate angio-
genic sprouting from preexisting vessels. Endothelial cells 
emerge from parent vessels and begin migrating outward 
using local guidance cues to ensure proper extension.2 As the 
sprout lengthens, extrinsic patterning cues provided by other 
cell types and the extracellular matrix guide the sprout toward 
other vessels or sprouts.3,4 A connection forms between the 
nascent sprout and its target, and this newly formed branch 
acquires a patent lumen for blood flow.5 A range of molecular 
mechanisms, including the vascular endothelial growth fac-
tor (VEGF) and Notch pathways, regulate these cellular pro-
cesses for vascular network expansion.
VEGF-A induces and directs endothelial cell sprouting. 
Binding of VEGF-A to the tyrosine kinase receptor Flk-1 
(VEGF receptor-2) initiates signaling in endothelial cells to 
promote migration, proliferation, and survival.6 Flt-1 (VEGF 
receptor-1) binds VEGF-A with 10-fold higher affinity than 
Flk-1 but acts primarily as a ligand sink, limiting the amount 
of VEGF-A that can access the Flk-1 receptors on the endo-
thelial cell surface.7 Both membrane-bound Flt-1 and soluble 
Flt-1 modulate endothelial cell proliferation,8 but soluble 
Flt-1 uniquely regulates vessel branching by contributing to a 
local sprout guidance mechanism.2 Expression of both VEGF 
receptors is regulated during sprouting angiogenesis as part 
of a dynamic competition among endothelial cells to lead the 
extending sprout,9 and the Notch pathway is important in the 
competition for tip cell position.
The Notch pathway facilitates cell–cell communication in 
many contexts, and it is important for lateral inhibition.10 As 
one cell acquires a particular role or fate, the Notch pathway is 
used to restrict neighboring cells from acquiring the same fate 
or phenotype, as seen in Drosophila trachea development,11 
and epidermal differentiation.12 Endothelial cells express the 
Notch1 and Notch4 receptors, as well as the ligands delta-
like 1 (Dll1), Dll4, Jagged1, and Jagged2.13 Ligand binding 
of Notch receptors leads to a series of enzymatic cleavages 
that result in release of the intracellular domain. The Notch 
intracellular domain translocates into the nucleus and forms a 
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Objective—Vascular endothelial growth factor (VEGF) signaling induces Notch signaling during angiogenesis. Flt-1/VEGF 
receptor-1 negatively modulates VEGF signaling. Therefore, we tested the hypothesis that disrupted Flt-1 regulation of 
VEGF signaling causes Notch pathway defects that contribute to dysmorphogenesis of Flt-1 mutant vessels.
Approach and Results—Wild-type and flt-1−/− mouse embryonic stem cell–derived vessels were exposed to pharmacological 
and protein-based Notch inhibitors with and without added VEGF. Vessel morphology, endothelial cell proliferation, and 
Notch target gene expression levels were assessed. Similar pathway manipulations were performed in developing vessels 
of zebrafish embryos. Notch inhibition reduced flt-1−/− embryonic stem cell–derived vessel branching dysmorphogenesis 
and endothelial hyperproliferation, and rescue of flt-1−/− vessels was accompanied by a reduction in elevated Notch 
targets. Surprisingly, wild-type vessel morphogenesis and proliferation were unaffected by Notch suppression, Notch 
targets in wild-type endothelium were unchanged, and Notch suppression perturbed zebrafish intersegmental vessels 
but not caudal vein plexuses. In contrast, exogenous VEGF caused wild-type embryonic stem cell–derived vessel and 
zebrafish intersegmental vessel dysmorphogenesis that was rescued by Notch blockade.
Conclusions—Elevated Notch signaling downstream of perturbed VEGF signaling contributes to aberrant flt-1−/− blood 
vessel formation. Notch signaling may be dispensable for blood vessel formation when VEGF signaling is below a critical 
threshold.  (Arterioscler Thromb Vasc Biol. 2013;33:1952-1959.)
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complex that activates the transcription of target genes, such 
as Hes and Hey. Notch coordinates vessel sprouting such that 
suppression of Notch signaling yields increased vessel sprout-
ing.9,14 The Notch pathway also negatively modulates endo-
thelial cell division, and reduced Notch signaling promotes 
endothelial cell proliferation.15
Crosstalk between the VEGF and Notch pathways is 
important for orchestrating endothelial cell behaviors dur-
ing angiogenesis.16,17 In response to VEGF stimulation, some 
endothelial cells initiate new sprouts and emerge as tip cells, 
whereas other cells follow as stalk cells and contribute to vessel 
expansion through proliferation.18 To accomplish this coordi-
nation, VEGF signals through Flk-1 to increase Dll4 expres-
sion on emerging tip cells. Tip cell Dll4 ligands engage Notch 
receptors on adjacent stalk cells to reduce their sensitivity to 
VEGF through increased expression of Flt-119,20 and reduced 
expression of Flk-1 and Flt-4.21–24 Here, we directly test the 
hypothesis that Flt-1 is critical to VEGF–Notch crosstalk in 
developing blood vessels. We show that Flt-1 is upstream of 
Notch signaling through regulation of VEGF signaling and 
thus mediates an important feedback loop in VEGF–Notch 
pathway crosstalk during blood vessel formation.
Materials and Methods
Materials and Methods are available in the online-only Supplement.
Results
Notch Inhibition Rescues Branching and 
Proliferation Defects in flt-1−/− Vessels
Loss of Flt-1 leads to vessel overgrowth and branching dys-
morphogenesis through elevated VEGF signaling.7,8,25 Because 
Notch signaling is activated by VEGF signaling,17 we hypoth-
esized that elevated VEGF signaling as a result of genetic loss 
of flt-1 increases Notch signaling and contributes to vessel 
branching defects. To test this hypothesis, we used differen-
tiation of mouse embryonic stem (ES) cells in vitro to form 
primitive lumenized vessel networks in the context of other 
embryonic cell types.26 Although these vessels lack blood 
flow, their development in vitro mimics in vivo development 
of primitive vessel networks.27 First, we manipulated Notch 
signaling during ES cell differentiation by incubation with 
the Notch inhibitor N-[N-(3,5-difluorophenacetyl)-L-alanyl]-
S-phenylglycine t-butyl ester (DAPT) during the angiogenic 
phase (days 6–8). Although wild-type (WT) tip cell numbers 
increased with Notch inhibition (Figure I in online-only Data 
Supplement), vessel branching and proliferation, as well as 
vessel area and diameter, were not significantly different from 
controls (Figure 1A–1C and 1G–1I; Figure IIA in online-only 
Data Supplement). Interestingly, loss of flt-1 (flt-1−/−) also led 
to increased tip cell numbers, despite an overall reduction in 
vessel branching (Figure I in online-only Data Supplement; 
Figure 1D–1G), suggesting the existence of multiple control 
points for successful branch formation. In contrast to Notch-
inhibited WT vessels, the reduced vessel branching of ES cell–
derived vessels lacking Flt-1 was rescued with Notch inhibition 
(Figure 1D–1G), despite no change in tip cell numbers with 
DAPT treatment (Figure I in online-only Data Supplement). 
Notch blockade also unexpectedly reduced the excessive endo-
thelial proliferation characteristic of flt-1−/− ES cell–derived 
vessels (Figure 1H). However, the increased vessel area and 
diameter of flt-1−/− vessels were not rescued by Notch blockade 
(Figure 1I; Figure IIA in online-only Data Supplement).
To further investigate Flt-1 interactions with Notch, we 
disrupted Notch signaling with Dll4-Fc, a competitive inhibi-
tor of Notch–Dll4 interactions.28 Similar to Notch inhibition 
with DAPT, WT ES cell–derived vessel branching, area, and 
endothelial cell mitotic index were unaffected by Dll4-Fc 
treatment (Figure 2A–2C and 2G–2I). However, the reduced 
vessel branching and elevated endothelial cell mitotic index of 
Figure 1. Notch inhibition by N-[N-(3,5-
difluorophenacetyl)-L-alanyl]-S-phenylglycine t-butyl 
ester (DAPT) rescues the dysmorphogenesis of 
flt-1−/− blood vessels. Wild-type ( WT; A–C) and flt-
1−/− (D–F) day 8 embryonic stem (ES) cell–derived 
vessels stained for platelet endothelial cell adhesion 
molecule (PECAM)-1. Scale bar, 100 μm. Day 8 ves-
sel networks assessed for branch points per vessel 
length (G). #P≤0.05 vs WT of same treatment group; 
*P≤0.05 vs flt-1−/−/untreated or flt-1−/−/dimethyl sulfox-
ide (DMSO). Day 7 vessel mitotic indices were quanti-
fied by counting phospho-histone H3+/PECAM-1+ 
cells and normalizing to total PECAM-1+ cells (H). 
###P≤0.0005 vs WT of same treatment group. 
***P≤0.0005 vs flt-1−/−/untreated or flt-1−/−/DMSO. 
Vessel area relative to total area for day 8 ES cell–
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flt-1−/− mutant vessels were normalized by Dll4-Fc exposure 
(Figure 2D–2H). Similar to DAPT-mediated Notch reduc-
tion, the vascular area of flt-1−/− ES cell–derived vessels was 
unchanged by Dll4-Fc (Figure 2D–2F and 2I). Taken together, 
these results indicate that although reduced Notch signaling 
increased WT tip cells, this did not affect WT vessel branch-
ing; in contrast, vessels lacking flt-1 function were phenotypi-
cally rescued by Notch blockade.
Because WT ES cell–derived vessels were unexpectedly phe-
notypically unaffected by Notch blockade, we asked whether 
this was a model-specific effect or evidence that Notch effects 
are also context dependent in vivo. To test this idea, we analyzed 
the developing vessels in the zebrafish embryo, an established 
model of blood vessel formation that occurs in the context of 
blood flow.29 Notch manipulations in zebrafish are reported to 
affect vessel formation in certain scenarios,30,31 but not all situ-
ations of vessel growth.32 Furthermore, the caudal vein plexus 
does not exhibit detectable Notch activation via Notch reporter 
readout (Wiley et al,33 in revision). Therefore, we subjected 
zebrafish embryos to Notch inhibition via DAPT treatment 
and analyzed them for vascular defects. We found perturbed 
intersegmental vessel (ISV) development in Notch-inhibited 
embryos (Figure 3A–3C), similar to previous reports.30,31 
However, in these same embryos, the caudal vein plexuses were 
unaffected, as determined by the presence of multiple lumen-
ized vessels conducting blood flow. (Figure 3A–3C). These 
observations demonstrate that effects of Notch inhibition on 
blood vessel formation in vivo are also context dependent.
VEGF-A–Disrupted Vessel Morphology 
Is Affected by Notch Blockade
Because loss of flt-1 elevates VEGF-A–mediated signaling,8 
we reasoned that the differences in response to Notch blockade 
between WT and flt-1−/− ES cell–derived vessels might result 
from the amount of VEGF signaling experienced by the vessels. 
Thus, we hypothesized that Notch inhibition would elicit 
changes in WT vessels exposed to ectopic VEGF-A. To test this 
idea, we inhibited Notch signaling in WT and flt-1−/− vessels 
with and without addition of exogenous VEGF-A. The added 
VEGF-A caused a significant decrease in WT vessel branch-
ing and an increase in endothelial proliferation and vessel area, 
suggesting that added VEGF-A recapitulates, although not 
fully, the loss of flt-1 (Figure 4A–4C and 4G–4I). Notch inhibi-
tion of VEGF-A–treated WT vessels partially normalized these 
changes (Figure 4A–4C and 4G–4I). VEGF-A treatment of 
flt-1−/− ES cell–derived vessels had no effect on vessel branch-
ing, area, or endothelial mitotic index, consistent with the idea 
that loss of Flt-1 elevates VEGF signaling independent of addi-
tional ligand (Figure 4D–4I). Exposure to ectopic VEGF-A 
and Notch blockade rescued flt-1−/− vessel branching dysmor-
phogenesis and endothelial mitotic index without vessel area 
rescue, similar to Notch blockade alone (Figure 4D–4I). These 
results indicate that WT vessels are not intrinsically defective 
in Notch-mediated responses, but rather that Notch responsive-
ness depends on the level of VEGF signaling.
We next manipulated VEGF and Notch signaling in zebraf-
ish embryos to further explore the influence of VEGF signal-
ing levels on the Notch responsiveness of developing blood 
vessels. Zebrafish ISVs are more sensitive to VEGF manip-
ulations than the caudal vein plexus.33 For this reason, we 
focused on ISV defects in Notch-inhibited embryos with and 
without the overexpression of Vegfaa via heat-shock induc-
tion of the Tg(hsp70l:vegfaa) transgene. Increased Vegfaa 
induced significant morphological perturbations in the ISVs 
of developing zebrafish (Figure 5A, 5C, and 5E). Notch 
blockade in embryos overexpressing Vegfaa led to an addi-
tional and significant increase in ISV defects (Figure 5B and 
5D–5F). Although zebrafish vessels exposed to Notch block-
ade, in conjunction with increased VEGF signaling, exhibited 
a distinct phenotypic outcome from ES cell–derived vessels, 
Figure 2. Flt-1−/− blood vessel dysmorphogenesis 
is rescued by delta-like 4 (Dll4)-Fc treatment. Wild-
type (WT; A–C) and flt-1−/− mutant (D–F) day 8 
embryonic stem (ES) cell–derived vessels stained for 
platelet endothelial cell adhesion molecule-1. Scale 
bar, 100 μm. Day 8 branch points were counted and 
normalized to vessel length (G). #P≤0.05 vs WT of 
same treatment group; *P≤0.05 vs flt-1−/−/untreated 
or flt-1−/−/BSA. Mitotic indices calculated for day 7 
vessels (H). ##P≤0.005 vs WT of same treatment 
group. **P≤0.005 vs flt-1−/−/untreated or flt-1−/−/BSA. 
Day 8 ES cell–derived vessels assessed for vascular 
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the interaction between the VEGF and Notch pathways was 
consistent between the 2 models as seen by the increase in 
defective zebrafish ISVs. Taken together, these observations 
indicate that endothelial cells vary in their responsiveness to 
Notch, depending on VEGF signaling levels.
Elevated Notch Target Gene Expression in  
flt-1−/− Vessels Is Rescued by Notch Blockade
To determine whether Notch pathway transcriptional targets 
are elevated in flt-1−/− mutant vessels, we dissociated WT and 
flt-1−/− ES cell cultures and used magnetic bead–assisted cell 
sorting to enrich for endothelial cells. Real-time quantitative 
polymerase chain reaction was used to assess RNA levels of the 
Notch targets hey1, dll4, and nrarp. As expected, Flt-1 RNA 
levels were reduced in enriched endothelial cell preparations 
from flt-1−/− vessels, whereas all 3 Notch targets were increased 
≥5-fold (Figure 6A). Interestingly, Notch target gene RNA 
levels in WT-enriched endothelial cell preparations showed no 
significant changes with Notch blockade (Figure 6Aii–6Aiv). 
In contrast, the elevated expression of Notch targets in flt-1−/− 
mutant preparations was rescued back down toward WT levels 
with Notch blockade (Figure 6Aii–6Aiv).
We next evaluated protein levels of Notch pathway compo-
nents in WT and flt-1−/− endothelial cell–enriched preparations 
exposed to Notch blockade. Protein levels of the transcription 
factor Hey1 and the Notch1 ligand Dll4, which are also Notch 
targets, were also highly elevated in the flt-1−/− EC-enriched 
preparations (Figure 6B). These elevated levels of Notch tar-
gets were partially rescued with Notch blockade. However, 
Notch targets were unchanged in WT EC-enriched prepara-
tions exposed to Notch blockade (Figure 6B). The lack of 
change in Notch target gene expression in the WT scenario 
supports the finding that Notch blockade does not affect the 
overall morphology of WT ES cell–derived vessels, whereas 
the elevation with loss of flt-1 and partial rescue with Notch 
blockade suggest that Notch is a required effector downstream 
of elevated VEGF signaling.
Discussion
The rescue of flt-1−/− ES cell–derived vessel branching dys-
morphogenesis by Notch blockade demonstrates that Flt-1 
regulation of VEGF signaling upstream of the Notch path-
way is critical for normal vascular development. In addition, 
VEGF overexpression in zebrafish impaired the ability of 
Flt-1 to modulate VEGF activity and induced ISV defects that 
were further affected by Notch suppression. Previous studies 
showed that Flt-1 expression was upregulated downstream of 
Notch signaling, but did not critically test flt-1 function in the 
crosstalk.9,20,22,34,35 Our data support an additional requirement 
for flt-1 upstream of Notch via modulation of VEGF signal-
ing. Thus, Flt-1 mediates a critical component of the feedback 
loop that governs coordination of endothelial cell behavior 
during vascular development (Figure 6C).
We propose that Flt-1 mediates crosstalk between the 
VEGF and Notch pathways by keeping VEGF signaling at 
appropriate levels to effectively use Notch for lateral inhibi-
tion (Figure 6Cii). Furthermore, Flt-1 completes the VEGF–
Notch feedback loop by further reinforcing the differential 
responsiveness of endothelial cells to the oncoming VEGF. 
Loss of Flt-1 modulation of VEGF signaling results in exces-
sively high Notch signaling, undermining the VEGF–Notch 
feedback loop and disrupting coordination of endothelial 
cell phenotypes (Figure 6Ciii). Thus, flt-1−/− endothelial 
cells are predicted to experience excessive lateral inhibition 
via Notch signaling. Consistent with this model, we found 
that the reduced branching and elevated endothelial prolif-
eration in flt-1−/− blood vessel networks25,36 were rescued by 
lowering elevated levels of Notch signaling through Notch 
blockade. Notch blockade in zebrafish ISVs exposed to ecto-
pic VEGF elicited additional changes in vessel morphology, 
suggesting that VEGF-mediated effects on vessel formation 
are influenced by Notch manipulation. RNA and protein lev-
els of Notch targets in ES cell–derived endothelial cells are 
Figure 3. Notch inhibition by N-[N-(3,5-difluorophenacetyl)-L-
alanyl]-S-phenylglycine t-butyl ester (DAPT) disrupts zebrafish 
intersegmental vessel (ISV) formation but has no effect on the 
developing caudal vein plexus (CVP). Dimethyl sulfoxide (DMSO)–
treated (A) and DAPT-treated (B) 48 hpf Tg(kdrl:GFP) zebrafish 
embryos. Scale bars, 100 μm. Embryos with normal  
(top inset, A) and defective ISVs (top inset, B), as well as normal 
(bottom inset, A and B) and defective CVPs, were quantified  
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consistent with the idea that loss of Flt-1 modulation of VEGF 
signaling leads to Notch hyperactivation. In this way, Notch 
signaling downstream of VEGF is required for the defects 
in flt-1−/− blood vessel formation. Bentley et al37 developed 
a computational model of VEGF and Notch signaling inter-
actions during vessel branching, and their simulation results 
suggested a need for Notch signaling (ie, lateral inhibition) 
to be turned down in situations of high VEGF signaling. The 
current study provides experimental evidence that Flt-1 regu-
lates the feedback loop between VEGF and Notch signaling 
to effectively turn down signaling levels of both pathways 
and thus supports proper coordination of endothelial cell 
behaviors.
Excessive flt-1−/− endothelial cell proliferation is reduced 
with Notch inhibition, suggesting a unique relationship 
between upstream Flt-1 regulation of VEGF signaling and 
the downstream Notch pathway in modulating endothelial 
proliferation. Increased Notch signaling causes endothelial 
cells to adopt a stalk cell phenotype14 but is also known to 
suppress endothelial cell proliferation.17,19,38–40 However, 
stalk cells are presumed to undergo division more frequently 
than tip cells for sprout elongation,18 which is seemingly 
incongruent with stalk cells experiencing elevated Notch 
signaling.14 Interestingly, flt-1 mutant endothelial cells 
overproliferate, despite having elevated levels of Notch sig-
naling, and both elevated Notch target levels and elevated 
Figure 4. Notch blockade rescues vessel defects 
induced by added vascular endothelial growth 
 factor (VEGF). VEGF-treated wild-type (WT; A–C) 
and flt-1−/− (D–F) day 8 embryonic stem (ES)  
cell–derived vessels stained for platelet endothelial 
cell adhesion molecule-1. Scale bar, 100 μm. Day 
8 vessels evaluated for branch points per ves-
sel length (G). *P≤0.05 vs WT/untreated or WT/
VEGF+N-[N-(3,5-difluorophenacetyl)-L-alanyl]-
S-phenylglycine t-butyl ester (DAPT); ##P≤0.002 
vs WT/untreated; ***P≤0.008 vs flt-1−/−/untreated, 
flt-1−/−/VEGF, or flt-1−/−/VEGF+dimethyl sulfoxide 
(DMSO). Mitotic indices of day 7 ES cell–derived 
vessels (H). *P≤0.05 vs WT/VEGF; **P≤0.01 vs 
WT/VEGF or WT/VEGF+DMSO; #P≤0.05 vs 
WT/untreated; ***P≤0.006 vs flt-1−/−/untreated, 
flt-1−/−/VEGF, or flt-1−/−/VEGF+DMSO. Day 8 
 vascular area (I). *P≤0.05 vs WT/VEGF or WT/
VEGF+DMSO; #P≤0.002 vs WT/untreated.  Values 
are averages±SEM.
Figure 5. Notch inhibition by N-[N-(3,5-
difluorophenacetyl)-L-alanyl]-S-phenylglycine 
t-butyl ester (DAPT) exacerbates vascular endo-
thelial growth factor (VEGF)-A–mediated zebrafish 
intersegmental vessel (ISV) defects. ISVs from 
dimethyl sulfoxide (DMSO)– and DAPT-treated 
wild-type (WT; A and B) and Tg(hsp70l:vegfaa; 
C and D) zebrafish embryos at 48 hpf visual-
ized by endothelial expression of green fluores-
cent protein [Tg(kdrl:GFP)]. Scale bar, 50 μm. 
Embryos with affected ISVs (B–D) were quanti-
fied, and penetrance was determined as the 
percent of embryos with an ISV phenotype (E). 
**P≤0.005 vs WT/DMSO; ##P≤0.007 vs WT/DMSO; 
*P≤0.016 vs Tg(hsp70l:vegfaa)/DMSO. Values are 
averages±SEM. Of the Tg(hsp70l:vegfaa) embryos 
with an ISV phenotype, the percent of somites with 
affected ISVs was determined (F). *P≤0.0001 for 
DMSO vs DAPT. Severities for individual zebrafish 
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endothelial cell division were rescued by Notch blockade. In 
one model consistent with these observations, flt-1−/− endo-
thelial cells have elevated lateral inhibition (Figure 6Ciii), 
and Notch blockade releases some endothelial cells from 
this lateral inhibition, allowing them to contribute more to 
branching and less to vessel expansion via proliferation. 
Nevertheless, further investigation will be required to eluci-
date how Flt-1 integrates VEGF and Notch signals to regu-
late endothelial cell division.
WT ES cell–derived vessels and zebrafish embryo caudal 
vein plexus exposed to Notch blockade showed no obvious 
changes in overall vessel morphology or endothelial cell pro-
liferation, despite an increase in tip cell numbers, and Notch 
blockade did not affect Notch target gene expression levels 
in WT endothelial cells. In contrast, Notch blockade in the 
postnatal retina, tumors, and wound healing models increases 
vessel density and branching, although these increases do not 
necessarily result in more lumenized conduits.14,22,41–43 Thus, 
an increase in tip cells may not inherently result in more pat-
ent vessel branches, as seen in the current study. Furthermore, 
not all Notch perturbations affect vessel branching, as previ-
ous observations of embryonic and yolk sac vessels in Notch-
manipulated mice revealed defects in network remodeling and 
arteriovenous specification rather than plexus formation.44–46 
These data and our results suggest that non-Notch pathways 
may act in parallel or in place of Notch to regulate vessel 
branching in certain situations. We hypothesized that the level 
of VEGF signaling might determine the involvement of Notch 
signaling in endothelial cells and thus their response to Notch 
blockade. Indeed, we found that adding VEGF ligand to ES 
cell–derived vessels or developing zebrafish ISVs affected 
vessel formation, and Notch blockade had additional effects 
on these vessels. These results are consistent with previous 
studies showing that endothelial cells respond to Notch inhibi-
tion more strongly with added VEGF.32,47,48 Thus, Notch-based 
therapies will need to be developed with consideration of the 
treatment context.
Pathological conditions, such as cancer and diabetes mel-
litus, have as hallmarks misregulated angiogenesis associated 
with aberrant VEGF signaling. Antiangiogenic therapies, par-
ticularly those targeting the VEGF pathway, have had limited 
success because of acquired resistance and suboptimal effi-
cacy.49 Notch perturbations in mouse tumor and hind-limb 
ischemia models increase the formation of poorly perfused 
vessels.41–43 This undermines recovery after ischemia,41 but 
for solid tumors it reduces tumor burden,42,43 supporting the 
potential for Notch-based cancer therapies. Thus, understand-
ing the systemic effects of disrupted Notch signaling50 and 
how Notch intersects with other pathways will be essential for 
development of effective treatments. In the present study, we 
found that Flt-1 is important in VEGF–Notch signaling cross-
talk and that loss of flt-1 disrupts VEGF signaling, which in 
turn perturbs the Notch pathway and contributes to flt-1−/− ves-
sel dysmorphogenesis.
Figure 6. Loss of endothelial flt-1 upregulates the 
Notch pathway. Flt-1−/− endothelial cell–enriched 
preparations increases Notch target RNAs (A). 
Real-time quantitative polymerase chain reaction 
of Flt-1 (Ai) and Notch pathway components Hey1 
(Aii), delta-like 4 (Dll4; Aiii), and Nrarp (Aiv) from 
untreated, vehicle control–treated, and N-[N-(3,5-
difluorophenacetyl)-L-alanyl]-S-phenylglycine 
t-butyl ester (DAPT)-treated wild-type (WT) and 
flt-1−/− endothelial cell–enriched preparations. 
Ai, #P≤0.05 vs WT of the same treatment group. 
Aii, #P≤0.05 vs WT of the same treatment group; 
*P≤0.05 vs flt-1−/−/untreated or flt-1−/−/dimethyl sulf-
oxide (DMSO). Aiii, ##P≤0.008 vs WT of the same 
treatment group; *P≤0.01 vs flt-1−/−/untreated or flt-
1−/−/DMSO. Aiv, #P≤0.05 vs WT of the same treat-
ment group; *P≤0.05 vs flt-1−/−/untreated or flt-1−/−/
DMSO. Values are averages+SEM. Flt-1−/− endo-
thelial cell–enriched preparations have elevated 
Notch target proteins (B). Representative Western 
blots for Dll4 (75 kDa) and Hey1 (34 kDa), as well 
as GAPDH (36 kDa) and actin (45 kDa; for normal-
ization), from untreated, vehicle control–treated, 
and DAPT-treated WT and flt-1−/− embryonic stem 
cell–derived endothelial cell–enriched preparations. 
Dll4 signal intensities were normalized to those 
for corresponding GAPDH control bands, and 
untreated WT levels were set to 1 for comparison 
(Bi). Hey1 levels were also compared across treat-
ment groups and cell types using actin control 
bands, just as described for Dll4 and GAPDH (Bii). Model of Flt-1–mediated crosstalk between the vascular endothelial growth factor 
(VEGF) and Notch pathways (C). The model illustrates how Flt-1 (blue), and soluble Flt-1 (sFlt-1) in particular (iia–iic), modulates the 
concentration of available VEGF (green, i–iii) that induces Dll4 expression in endothelial cells (red and pink cells, iia–iic). Notch signaling 
between adjacent cells (dotted lines in iic) then reinforces competition dynamics for sprouting (iic), which completes the Flt-1–mediated 
feedback loop between VEGF and Notch signaling pathways (iic). In the absence of Flt-1 activity (iiia–iiic), VEGF induces widespread 
activation of Dll4 (red cells, iiia–iiic), and thus Notch signaling is elevated, and normal competition dynamics among endothelial cells are 
disrupted (dotted lines in iiic). In addition, without Flt-1–mediated feedback, VEGF signaling is unchecked (iiic), exacerbating the exces-
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In the current study, we have shown that the vascular endothelial growth factor receptor Flt-1 plays an important role in the crosstalk be-
tween vascular endothelial growth factor and Notch signaling to coordinate endothelial cell dynamics during blood vessel formation. Previous 
studies showed that Notch signaling upregulates Flt-1 expression. Here, we have found evidence for an additional requirement for Flt-1 in 
regulating vascular endothelial growth factor signaling upstream of the Notch pathway. Thus, disrupted Flt-1 activity undermines this criti-
cal vascular endothelial growth factor–Notch feedback loop and perturbs the coordination of endothelial cells during angiogenesis. Because 
therapeutic strategies, particularly those treating solid tumors, are being developed to target these pathways, we believe our study addresses 
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